Track the companies that matter to you. It's FREE! Click one of these fan favorites to get started: Apple; Google; Ford.



Better Know a Stock Picker

Welcome, Fools, to part 43 of our several-thousand-part series, "Better Know a Stock Picker," which is loosely -- but not too loosely -- based on Stephen Colbert's "Better Know a District" from The Colbert Report.

Like Stephen and his thorough investigations into America's congressional districts, each week I take a look at a fund you may want to own. What's on tap this week?

Julius Baer International Equity (BJBIX)

Expense ratio


Fund size

$24.2 bil.

1-year return


5-year return


10-year return


Sources: Julius Baer, Morningstar

Top 5 holdings


% of Assets

OTP Bank


Komercni Banka


Vodafone Group (NYSE:VOD)




Nestle SA


Sources: Julius Baer

Meet Richard Pell and Rudolph-Riad Younes
The fightin' team at Julius Baer International Equity has been led by Richard Pell and Rudolph-Riad Younes since April 1995. They've been making investors rich ever since, as I can personally attest.

I've owned shares of International Equity since August 2003, and my position's doubled in that time. That's what happens when you own a fund that's ranked among the top 10 in its category in three of the last five years (No. 1 in 2002, No. 6 in 2004, and No. 5 last year).

Superior performance isn't new to Pell or Younes. According to Morningstar, International Equity has outdistanced the benchmark MSCI EAFE index by nearly 9% a year over the past decade. According to Kiplinger's, that record is good enough to place International Equity within the top 10% of global funds operating since 1996.

How they invest
Color me unsurprised. Younes told BusinessWeek in 2003 that he and Pell take a balanced approach. "I have one eye that can only see close and one that can only see far. As a money manager, that's what you want."

He's not joking. Younes really is cockeyed. He just sees it as a benefit, rather than a malady. Eat that, Wall Street.

And, while you're at it, how about adding a side dish of toughness? Younes is a native of Lebanon, having grown up, as he told BusinessWeek, with "people getting killed next to you." Anything must be simpler after that.

Indeed, what might seem tough for Wall Street's stockinistas, who run at the first sign of trouble, comes easy to Pell and Younes. They're still loading up on shares of market laggard GlaxoSmithKline (NYSE: GSK  ) , for example.

Why? Consider the big picture. Kiplinger's describes the pair as "big picture thinkers" who assess global economic trends, then place their bets for maximum returns. With hundreds of millions of people in developing nations suffering from disease, Glaxo's medicines should be in demand for decades.

Is this fund for you?
Could Younes and Pell best Peter Lynch in a stock-picking throwdown? I wouldn't bet on it, but I'd be hard pressed to bet against them, either. They've got too good a record.

And at 1.19% annually, International Equity's expense ratio is affordable at worst. That's why I still hold shares after nearly four years.

But if you're hoping to join me, I have good and bad news. First, the bad: International Equity is closed to new investors. Now, the good: a second International Equity Fund -- Julius Baer International Equity II (JETIX) -- was created in 2005, and Pell and Younes steer that ship as well. The expense ratio is also cheap, at 1.05% annually.

Will it ever join the ranks of the champions? I think so, even if Shannon Zimmerman has yet to add it to his list of foreign winners for Motley Fool Champion Funds. (Five of his international stock fund picks are beating their benchmarks. Want details? Click here to get 30 days of free access to Champion Funds.)

And that's today's profile. See you back here next week, fund nation. Good night.

For more Foolish coverage of investing globetrotters:

GlaxoSmithKline and Total SA are Income Investor picks. Vodafone is an Inside Value recommendation.

Fool contributor Tim Beyers, ranked 6,759 out of more than 28,900 in our Motley Fool CAPS investor intelligence database, is a regular viewer of The Colbert Report. (Stay the course.) Tim owned shares of Julius Baer International Equity at the time of publication. Tim's portfolio holdings can be found at his Fool profile. His thoughts on mutual funds, Foolishness, and investing in general may be found in his blog. The Motley Fool's disclosure policy is always championship caliber.

Read/Post Comments (0) | Recommend This Article (4)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

Compare Brokers

Fool Disclosure

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 528178, ~/Articles/ArticleHandler.aspx, 10/21/2016 4:19:34 PM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...

Today's Market

updated Moments ago Sponsored by:
DOW 18,145.71 -16.64 -0.09%
S&P 500 2,141.16 -0.18 -0.01%
NASD 5,257.40 15.57 0.30%

Create My Watchlist

Go to My Watchlist

You don't seem to be following any stocks yet!

Better investing starts with a watchlist. Now you can create a personalized watchlist and get immediate access to the personalized information you need to make successful investing decisions.

Data delayed up to 5 minutes

Related Tickers

10/21/2016 4:02 PM
GSK $41.13 Down -0.30 -0.72%
GlaxoSmithKline CAPS Rating: ***
TOT $48.28 Down -0.26 -0.54%
Total CAPS Rating: ****
VOD $27.77 Down -0.05 -0.18%
Vodafone CAPS Rating: ****